Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine for Corticosteroid Induced Memory Impairment
NCT01142310Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jun 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Memory impairment comparing Lamotrigine with Placebo (2 arms). Primary endpoint: Rey Auditory Verbal Learning Test at 48 weeks. Started Jun 2010; status: completed.
02
Drugs
lamotrigine
03
Conditions
Memory impairment
Beyond the preview
Go deeper on NCT01142310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01142310.